Our research focuses on patients and their wellbeing. The translational approach used by the GRIAC programme includes:
- Clinical and intervention studies on food and other allergies, asthma, and COPD;
- Large-scale clinical management in primary care.
The management of obstructive and pulmonary disease is slowly shifting towards precision medicine. The GRIAC research programme is in an excellent position to conduct intervention studies examining genomic markers. The GRIAC researchers are actively involved in the development of clinical questionnaires for disease diagnosis and monitoring disease control. Pulmonary rehabilitation and novel bronchoscopic intervention techniques as treatment options for COPD are currently being evaluated.
In 2012, a GRIAC researcher led the first large-scale intervention study on the role of tiotropium in asthma.
To learn from patients and to gain more insight into how they perceive the disease, three-monthly patient advisory board meetings are being held to use patient input for new projects and to reflect on completed projects. In addition, the patient advisory board has also been invited to share their views in the Master’s/PhD programme Translational Research in Respiratory Disease, which highlights the translational work conducted within the GRIAC programme.